Pharmacist-led intervention cuts medication errors and hospitalizations<\/p>\n<\/h3>\n
<\/b><\/p>\n
<\/b><\/p>\n
FRIDAY, May 14, 2021 (HealthDay News) — A pharmacist-led smartphone health app prevents medication errors and hospitalizations among kidney transplant recipients, according to a study published in the May issue of the Clinical Journal of the American Society of Nephrology<\/em>.<\/p>\n Haley M. Gonzales, Pharm.D., from the Medical University of South Carolina in Charleston, and colleagues evaluated the efficacy of improving medication safety through a pharmacist-led, mobile health-based intervention. Adult kidney recipients (136 patients; six to 36 months posttransplant) were randomly assigned to an intervention (supplemental clinical pharmacist-led medication therapy monitoring and management via a mobile health-based application, integrated with risk-guided televisits and home-based blood pressure and glucose monitoring) or usual care.<\/p>\n The researchers found that participants receiving the intervention experienced a significant reduction in medication errors (incident risk ratio, 0.39) and a significantly lower incidence risk for grade 3 or higher adverse events (incident risk ratio, 0.55). The intervention arm also showed significantly lower rates of hospitalizations (incident risk ratio, 0.46).<\/p>\n “It is paramount that we identify innovative strategies to help manage medication safety issues, and the integration of mobile health-based interventions and clinical pharmacist leadership represents a promising opportunity,” a coauthor said in a statement.<\/p>\n Two authors disclosed financial ties to the pharmaceutical industry.<\/p>\n Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n Editorial (subscription or payment may be required)<\/a><\/p>\n <\/i><\/p>\n